Aduro to Begin Testing ADU-S100 Combo in Phase 1b Trial for Lymphomas and Solid Tumors
News
U.S. regulators have cleared the way for Aduro Biotech to begin a Phase 1b clinical trial of a combination of ADU-S100 and Novartis’ PDR001 for treating lymphomas and advanced solid tumors or those that have spread. The green light ... Read more